Shareholders meeting

Mankind/II,._ September 17, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Subject: Voting results of Postal Ballot and Scrutinizer’s Report Ref.: Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) With reference to the captioned subject and in furtherance of our intimation dated August 18, 2026 regarding seeking approval of the members of the Company by way of Special Resolution through remote e-voting for the appointment of Mr. Anish Vanraj Bafna (DIN: 02925792) as a Non- Executive Independent Director of the Company for a term of five (5) consecutive years commencing from August 10, 2026, please find enclosed herewith: 1. Voting Results in the prescribed format as Annexure-I; and 2. Scrutinizer's Report as Annexure-II. The remote e-voting period commenced on Wednesday, August 19, 2026 at 09:00 AM (IST) and concluded on Thursday, September 17, 2026 at 05:00 PM (IST). Mr. Neelesh Kumar Jain, Practising Company Secretary (Membership No. F5593, C.P. No. 5233), Proprietor of M/s. N.K.J. & Associates, Company Secretaries, who was appointed as the Scrutinizer for the remote e-voting process, has submitted his Report dated September 17, 2026. Pursuant to the Scrutinizer’s Report, the aforesaid resolution has been passed by the members with the requisite majority and shall be deemed to have been passed on Thursday, September 17, 2026, being the last date of the remote e-voting period. Further, the voting results along with the Scrutinizer’s Report is available on the website of the Company at www.mankindpharma.com and on the website of NSDL at www.evoting.nsdl.com. You are requested to kindly take the same on record. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer Encl.: A/a MANKIND PHARMA LIMITED Regd. Office: 208, Okhla Ind. Estate, Phase -3, New Delhi-110020 •Ph.: 011-46846700, 47476600 CIN No. L74899DL 1991 PLC044843 •E-mail: contact@mankindpharma.com • www.mankindpharma.com Annexure-I General information about company Scrip code 543904 NSE Symbol MANKIND MSEI Symbol NOTLISTED ISIN INE634S01028 Name of the company Mankind Pharma Limited Type of meeting Postal Ballot Date of the meeting / last day of receipt of 17-09-2026 postal ballot forms (in case of Postal Ballot) Start time of the meeting End time of the meeting Scrutinizer Details Name of the Scrutinizer Neelesh Kumar Jain N.K.J. & Associates, Company Firms Name Secretaries Qualification CS Membership Number F5593 Date of Board Meeting in which appointed 10-08-2026 Date of Issuance of Report to the company 17-09-2026 Voting results Record date 14-08-2026 Total number of shareholders on record date 169721 No. of shareholders present in the meeting either in person or through proxy a) Promoters and Promoter group b) Public No. of shareholders attended the meeting through video conferencing a) Promoters and Promoter group b) Public No. of resolution passed in the meeting 1 Resolution (1) Resolution required: (Ordinary / Special) Special Whether promoter/promoter group are interested in the agenda/resolution? Appointment of Mr. Anish Vanraj Bafna (DIN: 02925792) as a Non-Executive Independent Description of resolution considered Director % of Votes polled No. of Mode of No. of shares No. of votes No. of votes % of votes in favour % of Votes against Category on outstanding votes – voting held polled – in favour on votes polled on votes polled shares against (1) (2) (3)=[(2)/(1)]*100 (4) (5) (6)=[(4)/(2)]*100 (7)=[(5)/(2)]*100 E-Voting 299960612 100.0000 299960612 0 100.0000 0.0000 Promoter Poll 0 0.0000 0 0 0.0000 0.0000 and Postal Ballot 299960612 Promoter (if 0 0.0000 0 0 0.0000 0.0000 Group applicable) Total 299960612 299960612 100.0000 299960612 0 100.0000 0.0000 E-Voting 85102048 93.0362 84955538 146510 99.8278 0.1722 Poll 0 0.0000 0 0 0.0000 0.0000 Public- Postal Ballot 91471960 Institutions (if 0 0.0000 0 0 0.0000 0.0000 applicable) Total 91471960 85102048 93.0362 84955538 146510 99.8278 0.1722 E-Voting 11142124 51.6714 11140823 1301 99.9883 0.0117 Poll 0 0.0000 0 0 0.0000 0.0000 Public- Non Postal Ballot 21563406 Institutions (if 0 0.0000 0 0 0.0000 0.0000 applicable) Total 21563406 11142124 51.6714 11140823 1301 99.9883 0.0117 Total Total 412995978 396204784 95.9343 396056973 147811 99.9627 0.0373 Whether resolution is Pass or Not. Yes Details of Invalid Votes Category No. of Votes Promoter and Promoter Group Public Insitutions 0 Public - Non Insitutions 0 Annexure-II NKJ &a ssociates COMPANY SECRETARIES Office: 312 & 313, The Address, Plot No. 4B, District Centre, MayurVihar Phase-1 Extension, Delhi-110091 (T): 011-43036786, (M): +91-9312284670, 9810554670 E-mail: nkj@nkj.co.in, Website: www.nkj.co.in Scrutinizer's Report !Pursuant to Section 110 of the Companies Act, 20l3 read with Rule 20 and Ruic 22 of the Companies (Management and Administration) Rules, 2014, as amended I The Chainnan, MANKIND PHARMA LIMJTED 208, Okhla Industrial Estate, Phase Ill, New Delhi I I 0020, Delhi, lndia Dear Sir, Sub: Scrutinizer's Report on the voting by means of remote e-voting process on the resolution set out in the Postal Ballot Notice dated August 10, 2026 I, Neelcsh Kumar Jain, Company Secretary in Practice (FCS: 5593/ CP No. 5233), have been appointed as Scrutinizer by the Board of Directors of MANKIND PHARMA LIMITED ("the Company") for the purpose of scrutinizing the voting by means of Postal Ballot, only by remote e-voting process ("e voting") in a fair and transparent manner on the resolution contained in the postal ballot notice dated August 10. 2026 ("Notice") sent in accordance with General Circular Nos. 14/2020 dated April 8, 2020 and 17/2020 dated April 13, 2020, read with other relevant circulars, including General Circular No. 03/2025 dated September 22, 2025, issued by the Ministry ofCorporatc Affairs, ("MCA"), Govemment of India (hereinafter referred to as "MCA Circulars"). 1. In compliance with the MCA Circulars, the Notice was sent through electronic mode to those members whose email address was registered with the Company/ Registrar & Transfer Agent of the Company, Depositories, viz. National Securities Depository Limited ("NSDL") / Central Depository Services (India) Limited ("CDSL") /Depository Participants as on Friday, August 14, 2026 ("Cut-Off Date"). The Notice was also placed on the website of the Company at: www.mankindpharrna.com, website of the Stock Exchanges, i.e., BSE Limited C-BSE") and National Stock Exchange of India Limited (''NSE") at www.bseindia.com and www.nscindia.com. respectively; and on the website of NSDL at https:// www.cvoting.nsdl.com. In compliance with the relevant MCA Circulars, a newspaper Advertisement was published on: August 19, 2026 in 'Financial Express· (English) and 'Jansatta' (Hindi) specifying the details of ct i spatch of Notice and instructions for e-voting. 2. ll1e said appointment as Scrutinizer is under the provisions of Section I 10 of the Companies Act, 2013 ("the Act") read with Rule 20 and Ruic 22 of the Companies (Management and Administration) Rules, 2014, as amended ("the Rules"). As the Scnitinizer, I have to scrutinize the process ofe-voting conducted for the postal ballot, using an electroni • ystem on the dates referred to in the Notice. ,._{, t Page 1 of 4 Management's Responsibility 3. The management of the Company is responsible to ensure compliance with the requirements of (i) the Act and the Rules made thereunder: (ii) the MCA Circulars; and (iii) the Securities and Exchange Boa.rd oflndia (Listing Obligations and Disclosure Requirements) Regulations 20 I 5, ("LODR ") relating to e-voting on the special resolution contained in the Notice. The management of the Company is [Showing first 8,000 characters — download PDF for full document]